A recognized syndrome of irritability, sleep disturbance, and physical discomfort following cessation of heavy, regular cannabis use.
Medically reviewed by
Dr. Mihaela G.
Cannabis Withdrawal describes a recognized cluster of symptoms emerging after stopping or significantly reducing heavy, regular cannabis use. This diagnosis, only formally added to DSM in the 2013 edition, directly challenges a persistent and widespread belief that cannabis simply doesn’t produce physical dependence, that stopping is a matter of choice without any physiological cost. For many regular, heavy users, this isn’t accurate.
The symptom picture is genuinely different from what people picture when they think “withdrawal,” there’s no dramatic medical emergency here, no seizures, no delirium. Instead, it’s a cluster of irritability, anxiety, sleep disturbance, decreased appetite, and physical restlessness that, while not medically dangerous, can be genuinely uncomfortable and is frequently a significant factor in relapse during attempts to quit, particularly when people don’t anticipate it and interpret the discomfort as a sign something else is wrong, or simply that they need cannabis again.
Understanding this syndrome clearly matters most for practical reasons: knowing what to expect, and that it’s temporary and a recognized, real physiological process rather than a personal failing, can meaningfully support someone through the discomfort of the first one to two weeks after stopping.
Irritability and mood symptoms
Irritability, anger, or aggression, alongside anxiety and nervousness, are among the most commonly reported symptoms, often emerging within the first day or two after stopping.
Sleep disturbance
Difficulty sleeping, including insomnia and disturbing dreams, is among the most consistently reported and disruptive symptoms, sometimes persisting longer than other withdrawal features.
Appetite and physical symptoms
Decreased appetite or weight loss, alongside physical symptoms including abdominal pain, tremor, sweating, fever, chills, or headache.
Restlessness
Physical restlessness, a felt sense of agitation or inability to settle, commonly accompanies the other symptoms.
Timeline
Symptoms typically begin within the first 24-72 hours after stopping, peak around the first week, and generally resolve within one to two weeks, though sleep disturbance in particular can sometimes persist somewhat longer.
⋅ Irritability, anger, or aggression in the days following cessation
⋅ Significant anxiety or nervousness
⋅ Depressed mood, in some presentations
⋅ Restlessness or a felt sense of agitation
⋅ Difficulty concentrating during the withdrawal period
⋅ Vivid or disturbing dreams, particularly connected to sleep disturbance
⋅ Preoccupation with cravings or thoughts of using again
⋅ Mild cognitive fog that typically improves as withdrawal resolves
⋅ Insomnia and significant sleep disturbance
⋅ Decreased appetite, sometimes with associated weight loss
⋅ Physical symptoms including abdominal pain, tremor, sweating, and headache
⋅ Physical restlessness and agitation
⋅ Difficulty maintaining usual sleep and eating patterns
⋅ Irritable or aggressive behavior toward others during the acute withdrawal period
⋅ Strong urges to resume use, particularly when symptoms feel uncomfortable
⋅ Relapse to cannabis use specifically to relieve withdrawal discomfort
Cannabis withdrawal occurs in roughly half of regular, heavy daily users who stop or significantly reduce their use, making it considerably more common than the popular perception of cannabis as a substance without physical dependence would suggest.
Risk factors for more significant withdrawal include longer duration and higher frequency of use, higher potency products, and co-occurring anxiety or mood conditions, which can both contribute to and be worsened by the withdrawal experience itself.
Comorbidity with cannabis use disorder is, by definition, closely connected, since withdrawal is one of the eleven diagnostic criteria for that condition, and recognizing withdrawal as a genuine factor in continued or relapsed use is an important part of understanding and treating the broader use disorder.
Cannabis withdrawal results from the same underlying neuroadaptation process seen across substance withdrawal syndromes, specific to the endocannabinoid system that cannabis directly affects.
Receptor downregulation occurs with sustained, heavy cannabis use; the body’s cannabinoid receptors adjust to the regular presence of THC, becoming less sensitive over time. When use stops, this downregulated system is left without its usual stimulation, producing the irritability, anxiety, and physical discomfort characteristic of withdrawal until the system gradually readjusts.
The relatively gradual elimination of THC from fat tissue, where it’s stored and released slowly, compared to faster-acting substances, likely explains some of the difference in withdrawal character compared to substances like alcohol or opioids; the onset is somewhat less abrupt, though still genuinely uncomfortable for many.
Individual factors, including the duration and intensity of prior use, individual differences in cannabinoid receptor sensitivity, and co-occurring anxiety or mood conditions, influence the specific severity and duration of withdrawal symptoms a given person experiences.
Cannabis Withdrawal is diagnosed based on cessation of cannabis use that has been heavy and prolonged, with three or more of the following developing within approximately one week: irritability/anger/aggression, nervousness/anxiety, sleep difficulty, decreased appetite/weight loss, restlessness, depressed mood, and at least one physical symptom (abdominal pain, tremor, sweating, fever, chills, or headache). Symptoms cause significant distress or impairment and aren’t attributable to another medical condition or better explained by another mental disorder, including intoxication or withdrawal from another substance.
Differential diagnosis requires distinguishing this from a primary anxiety or mood disorder, particularly given symptom overlap; the connection to recent cessation of heavy cannabis use and the expected resolution within one to two weeks helps clarify that the withdrawal syndrome, rather than an independent psychiatric condition, is the more likely explanation when timing fits this pattern.
Treatment for cannabis withdrawal is generally supportive, given that it’s not typically medically dangerous, though specific approaches can ease the discomfort considerably.
Education and expectation-setting
Simply knowing what to expect, the typical symptoms and timeline, helps many people tolerate the discomfort without misinterpreting it or relapsing prematurely, and is often an underappreciated but genuinely useful first step.
Symptom-specific supportive care
Addressing sleep disturbance specifically, sometimes with short-term, non-habit-forming sleep aids or good sleep hygiene practices, and managing appetite and physical discomfort with basic supportive measures, can ease the most disruptive aspects of withdrawal.
Behavioral support and therapy
Continuing or beginning cognitive-behavioral therapy during this period, addressing both the withdrawal discomfort and the broader patterns connected to use, supports successful navigation through this acute phase toward more sustained change.
No specific medication approved
There’s no medication specifically approved for cannabis withdrawal, though certain medications are sometimes used off-label to target specific symptoms, particularly sleep disturbance, as part of a broader, primarily behavioral treatment approach.
Know that this is temporary, typically resolving within one to two weeks. Understanding the expected timeline can help you tolerate the discomfort without assuming something is fundamentally wrong or that you need to resume use.
Prioritize sleep hygiene during this period, even though sleep disturbance is common. Consistent sleep timing, reduced screen time before bed, and a calm environment can help, even if sleep doesn’t fully normalize immediately.
Expect irritability and give yourself, and people around you, some grace during this window. Knowing this is a recognized, temporary symptom rather than a personal failing can ease some of the secondary distress around it.
Stay engaged with therapy or support during this period if you’re working on quitting more broadly. This acute discomfort window is often when relapse risk is highest, making continued support particularly valuable.
Address physical symptoms with basic supportive care. Staying hydrated, eating what you can even with reduced appetite, and gentle physical activity can help ease some of the physical discomfort.
The outlook for cannabis withdrawal is excellent; symptoms reliably resolve within one to two weeks without lasting physical harm, even though the experience can be genuinely uncomfortable in the moment.
The main risk connected to withdrawal isn’t medical danger but relapse; the discomfort, particularly irritability and sleep disturbance, is a well-documented contributor to resuming use during attempts to quit, making anticipating and managing these specific symptoms a meaningful part of successfully sustaining cessation.
With appropriate support and realistic expectations about the timeline and nature of symptoms, most people successfully move through this acute withdrawal period toward more lasting change in their use pattern.
Seek support if you’re planning to stop heavy, regular cannabis use and want guidance on managing withdrawal symptoms, particularly sleep disturbance and irritability, which are among the most disruptive features.
Seek evaluation if symptoms feel severe or aren’t improving within the expected one to two week window, since this might suggest another contributing factor worth assessing.
Seek ongoing treatment for the underlying use pattern, given how often withdrawal discomfort contributes to relapse, continued engagement with therapy or support during this period can meaningfully improve your chances of sustaining the change you’re working toward.
Someone in your life might be quietly looking for this. Share it:
These conditions share overlapping symptoms and are often misdiagnosed.
No, unlike withdrawal from alcohol or certain other substances, cannabis withdrawal is not considered medically dangerous. It involves uncomfortable symptoms like irritability, anxiety, sleep disturbance, and physical discomfort, but doesn’t carry the same risk of seizures or other serious medical complications. The main concern connected to cannabis withdrawal is that the discomfort can contribute to relapse during attempts to quit, rather than any direct medical danger.
Symptoms typically begin within the first 24 to 72 hours after stopping, peak around the first week, and generally resolve within one to two weeks. Sleep disturbance specifically can sometimes persist a bit longer than other symptoms for some people, but the overall withdrawal syndrome is time-limited and resolves without specific medical treatment for the large majority of people.
Cannabis withdrawal was only formally recognized as a diagnosis in the 2013 edition of the DSM, considerably later than withdrawal syndromes for substances like alcohol or opioids. This, combined with cannabis’s broader cultural reputation as non-physically-dependence-forming, has meant public awareness of this genuine, recognized syndrome has lagged behind the clinical evidence, even though it occurs in roughly half of regular, heavy daily users who stop.
Knowing what to expect and the typical one-to-two-week timeline helps many people tolerate the discomfort without relapsing prematurely. Good sleep hygiene practices, staying hydrated, eating what you can despite reduced appetite, and continued engagement with therapy or support during this period can all help ease the transition. There’s no medication specifically approved for cannabis withdrawal, though certain medications are sometimes used off-label for specific symptoms like sleep disturbance.
Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry, 161(11), 1967–1977. PubMed
Bonnet, U., & Preuss, U. W. (2017). The cannabis withdrawal syndrome: current insights. Substance Abuse and Rehabilitation, 8, 9–37. PubMed
Allsop, D. J., Copeland, J., Norberg, M. M., Fu, S., Molnar, A., Lewis, J., & Budney, A. J. (2012). Quantifying the clinical significance of cannabis withdrawal. PLoS One, 7(9), e44864. PubMed
Gorelick, D. A., Levin, K. H., Copersino, M. L., Heishman, S. J., Liu, F., Boggs, D. L., & Kelly, D. L. (2012). Diagnostic criteria for cannabis withdrawal syndrome. Drug and Alcohol Dependence, 123(1-3), 141–147. PubMed
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021). Cannabis use and cannabis use disorder. Nature Reviews Disease Primers, 7, 16. PubMed
